![]() Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | |||
Founding Date | Founding Date 2000 | Founding Date 1948 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Heidelberg, DE HQ | Locations South San Francisco, US HQ | |
Employees | Employees 76 | Employees 650 | Employees 11914% increase |
Financial | |||
Revenue (est.) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods £221m (FY, 2019) | Cost of goods N/A |
Gross profit | Gross profit €13m (FY, 2023) | Gross profit £510.3m (FY, 2019) | Gross profit N/A |
Net income | Net income (€105.9m) (FY, 2023) | Net income £88.3m (FY, 2019) | Net income ($176.6m) (FY, 2021) |

Tricida operates in the healthcare industry focusing on pharmaceutical business.
View company